claritev corp - CTEV
CTEV
Close Chg Chg %
57.11 0.29 0.50%
Open Market
57.39
+0.29 (0.50%)
Volume: 2.05K
Last Updated:
Sep 17, 2025, 9:46 AM EDT
Company Overview: claritev corp - CTEV
CTEV Key Data
| Open $57.05 | Day Range 57.05 - 57.88 |
| 52 Week Range 4.80 - 74.07 | Market Cap $940.22M |
| Shares Outstanding 16.47M | Public Float 7.18M |
| Beta 0.58 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$40.96 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 103.67K |
CTEV Performance
| 1 Week | -7.17% | ||
| 1 Month | -20.30% | ||
| 3 Months | 42.68% | ||
| 1 Year | 658.51% | ||
| 5 Years | -87.34% |
CTEV Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
3
Full Ratings ➔
About claritev corp - CTEV
Claritev Corp. engages in providing data analytics and technology-enabled solutions. It focuses on analytics-based services, data and decision science services, network-based services, payment and revenue integrity services, surprise billing services, and MultiPlan payments. The company was founded in 1980 and is headquartered in McLean, VA.
CTEV At a Glance
Claritev Corp.
7900 Tysons One Place
McLean, Virginia 22102
| Phone | 1-212-780-2000 | Revenue | 930.62M | |
| Industry | Data Processing Services | Net Income | -1,645,831,000.00 | |
| Sector | Technology Services | Employees | 2,700 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
CTEV Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.256 |
| Price to Book Ratio | 2.848 |
| Price to Cash Flow Ratio | 2.23 |
| Enterprise Value to EBITDA | 8.829 |
| Enterprise Value to Sales | 5.104 |
| Total Debt to Enterprise Value | 0.956 |
CTEV Efficiency
| Revenue/Employee | 344,675.556 |
| Income Per Employee | -609,567.037 |
| Receivables Turnover | 10.368 |
| Total Asset Turnover | 0.15 |
CTEV Liquidity
| Current Ratio | 0.821 |
| Quick Ratio | 0.821 |
| Cash Ratio | 0.139 |
CTEV Profitability
| Gross Margin | 27.847 |
| Operating Margin | 10.919 |
| Pretax Margin | -190.271 |
| Net Margin | -176.852 |
| Return on Assets | -26.439 |
| Return on Equity | -183.569 |
| Return on Total Capital | -35.584 |
| Return on Invested Capital | -30.292 |
CTEV Capital Structure
| Total Debt to Total Equity | 5,404.795 |
| Total Debt to Total Capital | 98.183 |
| Total Debt to Total Assets | 84.975 |
| Long-Term Debt to Equity | 5,383.807 |
| Long-Term Debt to Total Capital | 97.802 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Claritev Corp - CTEV
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.12B | 1.08B | 961.52M | 930.62M | |
Sales Growth
| +19.18% | -3.39% | -10.95% | -3.21% | |
Cost of Goods Sold (COGS) incl D&A
| 580.39M | 613.39M | 655.49M | 671.48M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 412.06M | 415.66M | 425.79M | 436.44M | |
Depreciation
| 71.85M | 75.12M | 83.09M | 92.55M | |
Amortization of Intangibles
| 340.21M | 340.54M | 342.69M | 343.88M | |
COGS Growth
| -18.71% | +5.69% | +6.86% | +2.44% | |
Gross Income
| 537.22M | 466.33M | 306.04M | 259.15M | |
Gross Income Growth
| +140.03% | -13.20% | -34.37% | -15.32% | |
Gross Profit Margin
| +48.07% | +43.19% | +31.83% | +27.85% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 131.99M | 132.14M | 132.63M | 157.53M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 131.99M | 132.14M | 132.63M | 157.53M | |
SGA Growth
| -62.89% | +0.12% | +0.37% | +18.77% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 2.35M | 595.31M | (44.51M) | 1.55B | |
EBIT after Unusual Expense
| 402.87M | (261.13M) | 217.91M | (1.45B) | |
Non Operating Income/Expense
| 55.00K | 3.79M | 8.23M | 8.14M | |
Non-Operating Interest Income
| 30.00K | 3.50M | 8.23M | 3.13M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 267.48M | 303.40M | 333.21M | 331.38M | |
Interest Expense Growth
| -20.31% | +13.43% | +9.82% | -0.55% | |
Gross Interest Expense
| 267.48M | 303.40M | 333.21M | 331.38M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 135.45M | (560.74M) | (107.06M) | (1.77B) | |
Pretax Income Growth
| +124.77% | -513.98% | +80.91% | -1,553.94% | |
Pretax Margin
| +12.12% | -51.93% | -11.13% | -190.27% | |
Income Tax
| 33.37M | 12.17M | (15.36M) | (124.88M) | |
Income Tax - Current - Domestic
| 115.30M | 126.55M | 98.70M | 73.13M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| (81.93M) | (114.38M) | (114.06M) | (198.01M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 102.08M | (572.91M) | (91.70M) | (1.65B) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 102.08M | (572.91M) | (91.70M) | (1.65B) | |
Net Income Growth
| +119.61% | -661.24% | +83.99% | -1,694.86% | |
Net Margin Growth
| +9.13% | -53.06% | -9.54% | -176.85% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 102.08M | (572.91M) | (91.70M) | (1.65B) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 102.08M | (572.91M) | (91.70M) | (1.65B) | |
EPS (Basic)
| 6.272 | -35.8672 | -5.6856 | -101.9248 | |
EPS (Basic) Growth
| +114.18% | -671.86% | +84.15% | -1,692.68% | |
Basic Shares Outstanding
| 16.28M | 15.97M | 16.13M | 16.15M | |
EPS (Diluted)
| 6.2672 | -35.8672 | -5.6856 | -101.9248 | |
EPS (Diluted) Growth
| +114.17% | -672.30% | +84.15% | -1,692.68% | |
Diluted Shares Outstanding
| 16.29M | 15.97M | 16.13M | 16.15M | |
EBITDA
| 817.28M | 749.84M | 599.19M | 538.05M | |
EBITDA Growth
| +200.63% | -8.25% | -20.09% | -10.20% | |
EBITDA Margin
| +73.13% | +69.45% | +62.32% | +57.82% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 56.333 | |
| Number of Ratings | 3 | Current Quarters Estimate | -3.831 | |
| FY Report Date | 09 / 2025 | Current Year's Estimate | -15.73 | |
| Last Quarter’s Earnings | -3.81 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -101.92 | Next Fiscal Year Estimate | -11.195 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 3 | 3 | 3 | 3 |
| Mean Estimate | -3.83 | -3.72 | -15.73 | -11.19 |
| High Estimates | -3.12 | -3.07 | -14.36 | -9.25 |
| Low Estimate | -4.70 | -4.58 | -17.47 | -13.56 |
| Coefficient of Variance | -20.99 | -20.87 | -10.09 | -19.55 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 2 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Claritev Corp - CTEV
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Claritev Corp - CTEV
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 13, 2025 | Travis S. Dalton Pres., CEO & Executive Chair; Director | 300 | Open market or private purchase of non-derivative security Non-derivative transaction at $54.21 per share | 16,263.00 |
| Aug 13, 2025 | Travis S. Dalton Pres., CEO & Executive Chair; Director | 4,282 | Open market or private purchase of non-derivative security Non-derivative transaction at $58.3 per share | 249,640.60 |
| May 21, 2025 | Jerome W. Hogge EVP, Chief Operating Officer | 84,402 | Open market or private purchase of non-derivative security Non-derivative transaction at $27.94 per share | 2,358,191.88 |
| May 21, 2025 | Douglas Garis EVP&CFO | 143,861 | Open market or private purchase of non-derivative security Non-derivative transaction at $27.73 per share | 3,989,265.53 |
| Apr 2, 2025 | Michael C. Kim EVP, Chief Digital Officer | 95,929 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.77 per share | 1,992,445.33 |
| Apr 2, 2025 | Dale A. White Director | 361,732 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.77 per share | 7,513,173.64 |
| Apr 2, 2025 | Gerald J. Kozel SVP, Chief Accounting Officer | 57,815 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.77 per share | 1,200,817.55 |
| Apr 2, 2025 | Neil Tara O SVP, General Counsel | 23,963 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.77 per share | 497,711.51 |
| Mar 11, 2025 | Douglas Garis EVP&CFO | 345 | Open market or private purchase of non-derivative security Non-derivative transaction at $21.08 per share | 7,272.60 |
| Mar 11, 2025 | Douglas Garis EVP&CFO | 336 | Open market or private purchase of non-derivative security Non-derivative transaction at $20.8 per share | 6,988.80 |